Gilead Sciences
GILD
#134
Rank
S$211.07 B
Marketcap
S$170.23
Share price
1.80%
Change (1 day)
20.13%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): S$9.52

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$9.48. In 2025 the company made an earnings per share (EPS) of S$8.75 an increase over its 2024 EPS that were of S$0.49.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$9.528.78%
2025S$8.751702.63%
2024S$0.49-91.65%
2023S$5.8123.98%
2022S$4.69-25.86%
2021S$6.334850%
2020S$0.13-97.64%
2019S$5.420.9%
2018S$5.3718.71%
2017S$4.52-64.88%
2016S$12.88-18.45%
2015S$15.7955.28%
2014S$10.17296.02%
2013S$2.5717.89%
2012S$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.16 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.67-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.63-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.07 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.50 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$11.95 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.07-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$21.74 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.57-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA